This is a meeting of the Hemophilia Medical Advisory Panel (HMAP) formed to assist with the Agency’s Comprehensive Hemophilia Disease Management Programs. Business is to review first quarterly reports of the Comprehensive Hemophilia Disease Management Program. Discussion will include development of provider and recipient satisfaction surveys, any pending business, and introduction of new business. The purpose of HMAP is to develop clinical guidelines; review and recommend care protocols; suggest appropriate outreach methods to beneficiaries; and review difficult cases and make recommendations.